191 related articles for article (PubMed ID: 30090722)
1. Study of Visceral and Subcutaneous Abdominal Fat Thickness and Its Correlation with Cardiometabolic Risk Factors and Hormonal Parameters in Polycystic Ovary Syndrome.
Jena D; Choudhury AK; Mangaraj S; Singh M; Mohanty BK; Baliarsinha AK
Indian J Endocrinol Metab; 2018; 22(3):321-327. PubMed ID: 30090722
[TBL] [Abstract][Full Text] [Related]
2. Visceral adiposity and inflammatory bowel disease.
Rowan CR; McManus J; Boland K; O'Toole A
Int J Colorectal Dis; 2021 Nov; 36(11):2305-2319. PubMed ID: 34104989
[TBL] [Abstract][Full Text] [Related]
3. Body Composition, Metabolic Characteristics, and Insulin Resistance in Obese and Nonobese Women with Polycystic Ovary Syndrome.
Satyaraddi A; Cherian KE; Kapoor N; Kunjummen AT; Kamath MS; Thomas N; Paul TV
J Hum Reprod Sci; 2019; 12(2):78-84. PubMed ID: 31293320
[TBL] [Abstract][Full Text] [Related]
4. Serum leptin in obese women with polycystic ovary syndrome is correlated with body weight and fat distribution but not with androgen and insulin levels.
Vicennati V; Gambineri A; Calzoni F; Casimirri F; Macor C; Vettor R; Pasquali R
Metabolism; 1998 Aug; 47(8):988-92. PubMed ID: 9711997
[TBL] [Abstract][Full Text] [Related]
5. Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome.
Pasquali R; Gambineri A; Biscotti D; Vicennati V; Gagliardi L; Colitta D; Fiorini S; Cognigni GE; Filicori M; Morselli-Labate AM
J Clin Endocrinol Metab; 2000 Aug; 85(8):2767-74. PubMed ID: 10946879
[TBL] [Abstract][Full Text] [Related]
6. Quantification of visceral adipose tissue in polycystic ovary syndrome: dual-energy X-ray absorptiometry versus magnetic resonance imaging.
Frøssing S; Nylander MC; Chabanova E; Kistorp C; Skouby SO; Faber J
Acta Radiol; 2018 Jan; 59(1):13-17. PubMed ID: 28534418
[TBL] [Abstract][Full Text] [Related]
7. Elevated levels of interleukin-18 are associated with several indices of general and visceral adiposity and insulin resistance in women with polycystic ovary syndrome.
Kabakchieva P; Gateva A; Velikova T; Georgiev T; Yamanishi K; Okamura H; Kamenov Z
Arch Endocrinol Metab; 2022 Mar; 66(1):3-11. PubMed ID: 35263047
[TBL] [Abstract][Full Text] [Related]
8. Circulating levels of obestatin and copeptin in obese and nonobese women with polycystic ovary syndrome.
Taskin MI; Bulbul E; Adali E; Hismiogulları AA; Inceboz U
Eur J Obstet Gynecol Reprod Biol; 2015 Jun; 189():19-23. PubMed ID: 25837320
[TBL] [Abstract][Full Text] [Related]
9. Visceral Adiposity Index: Simple Tool for Assessing Cardiometabolic Risk in Women with Polycystic Ovary Syndrome.
Agrawal H; Aggarwal K; Jain A
Indian J Endocrinol Metab; 2019; 23(2):232-237. PubMed ID: 31161109
[TBL] [Abstract][Full Text] [Related]
10. Association between circulating neuregulin 4 levels and metabolic, aterogenic, and AMH profile of polycystic ovary syndrome.
Kurek Eken M; Sahin Ersoy G; Yayla Abide C; Sanverdi İ; Devranoglu B; Kutlu T; Çevik Ö
J Obstet Gynaecol; 2019 Oct; 39(7):975-980. PubMed ID: 31064233
[TBL] [Abstract][Full Text] [Related]
11. Expression of 11β-hydroxysteroid dehydrogenase type 1 in visceral and subcutaneous adipose tissues of patients with polycystic ovary syndrome is associated with adiposity.
Mlinar B; Marc J; Jensterle M; Bokal EV; Jerin A; Pfeifer M
J Steroid Biochem Mol Biol; 2011 Feb; 123(3-5):127-32. PubMed ID: 21147223
[TBL] [Abstract][Full Text] [Related]
12. Indirect Predictors of Visceral Adipose Tissue in Women with Polycystic Ovary Syndrome: A Comparison of Methods.
Kałużna M; Czlapka-Matyasik M; Bykowska-Derda A; Moczko J; Ruchala M; Ziemnicka K
Nutrients; 2021 Jul; 13(8):. PubMed ID: 34444654
[TBL] [Abstract][Full Text] [Related]
13. Subcutaneous adipose tissue topography and metabolic disturbances in polycystic ovary syndrome.
Wehr E; Möller R; Horejsi R; Giuliani A; Kopera D; Schweighofer N; Groselj-Strele A; Pieber TR; Obermayer-Pietsch B
Wien Klin Wochenschr; 2009; 121(7-8):262-9. PubMed ID: 19562283
[TBL] [Abstract][Full Text] [Related]
14. Visceral adiposity index levels in overweight and/or obese, and non-obese patients with polycystic ovary syndrome and its relationship with metabolic and inflammatory parameters.
Durmus U; Duran C; Ecirli S
J Endocrinol Invest; 2017 May; 40(5):487-497. PubMed ID: 27838846
[TBL] [Abstract][Full Text] [Related]
15. Correlation of Markers of Inflammation with Hormonal, Metabolic Parameters, Insulin Resistance and Adiposity Indices in First-Degree Relatives of Patient with Polycystic Ovary Syndrome.
Pradhan J; Mishra I; Rattan R; Choudhury AK; Baliarsinha AK
J Hum Reprod Sci; 2022; 15(3):250-258. PubMed ID: 36341014
[TBL] [Abstract][Full Text] [Related]
16. The relationship between visceral adiposity and cardiometabolic risk in Chinese women with polycystic ovary syndrome.
Ng NYH; Liu KH; Tam CHT; Jiang G; Cheng F; Hou Y; Yau TT; Ozaki R; Chan MH; Lim CK; Sahota DS; Li TC; Cheung LP; Tam WH; Chu WCW; Ma RCW
Obes Res Clin Pract; 2021; 15(6):593-599. PubMed ID: 34561173
[TBL] [Abstract][Full Text] [Related]
17. Enlarged adipocytes in subcutaneous adipose tissue associated to hyperandrogenism and visceral adipose tissue volume in women with polycystic ovary syndrome.
Echiburú B; Pérez-Bravo F; Galgani JE; Sandoval D; Saldías C; Crisosto N; Maliqueo M; Sir-Petermann T
Steroids; 2018 Feb; 130():15-21. PubMed ID: 29273198
[TBL] [Abstract][Full Text] [Related]
18. Left ventricular myocardial mass index and its correlates as an early marker of cardiovascular risk among nonobese normotensive Indian women with polycystic ovary syndrome: lessons from a cross-sectional study.
Rashid A; Masood A; Wani IA; Hafeez I; Parvez T; Zagar MA; Ganie MA
Fertil Steril; 2020 Jun; 113(6):1299-1307.e2. PubMed ID: 32482259
[TBL] [Abstract][Full Text] [Related]
19. Effects of endogenous androgens and abdominal fat distribution on the interrelationship between insulin and non-insulin-mediated glucose uptake in females.
Ezeh U; Pall M; Mathur R; Dey D; Berman D; Chen IY; Dumesic DA; Azziz R
J Clin Endocrinol Metab; 2013 Apr; 98(4):1541-8. PubMed ID: 23450052
[TBL] [Abstract][Full Text] [Related]
20. The novel predictor of metabolic risk in patients with polycystic ovary syndrome: could it be the visceral adiposity index?
Apaydin M; Kazan ED; Beysel S; Sari A; Özgül E; Cengiz H; Demirci T; Yilmazer M
Eur Rev Med Pharmacol Sci; 2022 Oct; 26(19):7182-7187. PubMed ID: 36263527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
